title: Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis.
abstract: BACKGROUND
  Preterm birth (PTB) is the major determinant of perinatal morbidity and mortality. Infection is implicated in a large proportion of preterm deliveries, but there is no consensus regarding the efficacy of antibiotic prophylaxis for women at risk.
  
  
  OBJECTIVE
  To determine whether antibiotic treatment reduces the risk of preterm delivery in asymptomatic pregnant women at risk of PTB.
  
  
  METHODS
  Relevant publications were identified via electronic searches of MEDLINE (1966 to August 2005), The Cochrane Pregnancy and Childbirth Group trials register, the Cochrane Central Register of Controlled Trials (the Cochrane Library, Issue 3, 2005) and PubMed using multiple search terms related to PTB and antibiotics. Publications were limited to randomised controlled trials comparing antibiotics with placebo given to asymptomatic non-labouring women. A random effect model was used, and combined risk ratios calculated for the various risk groups. Associations between treatment effect and the rate of PTB were analysed by meta-regression.
  
  
  RESULTS
  Seventeen trials were included, 12 identifying women at risk by abnormal vaginal flora, three on women at high risk from a previous PTB and two recruiting women based on positive fetal fibronectin status. There was no significant association between antibiotic treatment and reduction in PTB irrespective of criteria used to assess risk, the antimicrobial agent administered, or gestational age at time of treatment (overall combined random effect for delivery at less than 37 weeks RR 1.03 (95% CI 0.86-1.24)).
  
  
  CONCLUSIONS
  Treating women at risk of PTB with antibiotics does not reduce the risk of subsequent PTB.
authors: Maternal and Fetal Research Unit, Division of Reproduction and Endocrinology, King's College London School of Medicine at Guy's, King's College and St. Thomas' Hospitals, London, UK. rach.simcox@kcl.ac.uk
authors: Rachael
authors: R
authors: Simcox
authors: Wing-To A
authors: WT
authors: Sin
authors: Paul T
authors: PT
authors: Seed
authors: Annette
authors: A
authors: Briley
authors: Andrew H
authors: AH
authors: Shennan
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D015415:Biomarkers / Q000097:blood; D005260:Female; D005312:Fetal Blood; D005353:Fibronectins / Q000097:blood; D006801:Humans; D011247:Pregnancy; D047928:Premature Birth / Q000517:prevention & control*; D012307:Risk Factors; D014621:Vagina / Q000382:microbiology; D016585:Vaginosis, Bacterial / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D015415:Biomarkers; D005353:Fibronectins